Right now, patients with obesity and cirrhosis have few treatments for their progressive liver disease, but a new study ...
Hepatic encephalopathy is a liver disease that affects the brain. Learn how a new treatment can treat the disease and prevent ...
Akero reported Monday strong results showing its drug efruxifermin reversed liver scarring in patients with cirrhosis caused ...
Beta-blockers have been a standard treatment for managing portal hypertension for many years. However, they are effective in ...
A Cleveland Clinic study reveals that bariatric surgery significantly reduces the risk of serious liver complications in ...
Akero Therapeutics shares traded near their all-time high as the drugmaker reported positive results in a study of its treatment for liver disease.
News Medical on MSN2d
Weight-loss surgery lowers risk of developing complications of liver disease in patients with cirrhosis and obesityCLEVELAND: A Cleveland Clinic study shows that patients with obesity and fatty liver-related cirrhosis who had bariatric (weight-loss) surgery significantly lowered their future risk of developing ...
After missing the primary endpoint in the Phase IIb SYMMETRY trial, Akero Therapeutics’ lead molecule, efruxifermin, showed ...
On today’s CT Buzz, Host Natasha Lubczenko welcomed Dr. Housein Wazaz, MD, a Gastroenterologist from MidState ...
Most ICBs in England do not have effective referral pathways for diagnosing and managing liver disease, an analysis has shown ...
Metabolic dysfunction-associated steatotic liver disease (MASLD), previously known as non-alcoholic fatty liver disease, is the most common cause of chronic liver disease in children. MASLD ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results